172 related articles for article (PubMed ID: 12112527)
41. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
42. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.
Parikh RA; White JS; Huang X; Schoppy DW; Baysal BE; Baskaran R; Bakkenist CJ; Saunders WS; Hsu LC; Romkes M; Gollin SM
Genes Chromosomes Cancer; 2007 Aug; 46(8):761-75. PubMed ID: 17492757
[TBL] [Abstract][Full Text] [Related]
43. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
[TBL] [Abstract][Full Text] [Related]
44. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
45. Disruption of the ATM gene in breast cancer.
Lu Y; Condie A; Bennett JD; Fry MJ; Yuille MR; Shipley J
Cancer Genet Cytogenet; 2001 Apr; 126(2):97-101. PubMed ID: 11376801
[TBL] [Abstract][Full Text] [Related]
46. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients.
Chan MW; Chan LW; Tang NL; Lo KW; Tong JH; Chan AW; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Int J Cancer; 2003 May; 104(5):611-6. PubMed ID: 12594816
[TBL] [Abstract][Full Text] [Related]
47. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
48. [A novel tumor suppressor gene, TSLC1].
Murakami Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():121-4. PubMed ID: 11761925
[No Abstract] [Full Text] [Related]
49. Fez1/lzts1 alterations in gastric carcinoma.
Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.
Laake K; Odegård A; Andersen TI; Bukholm IK; Kåresen R; Nesland JM; Ottestad L; Shiloh Y; Børresen-Dale AL
Genes Chromosomes Cancer; 1997 Mar; 18(3):175-80. PubMed ID: 9071570
[TBL] [Abstract][Full Text] [Related]
51. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients.
Flanagan JM; Munoz-Alegre M; Henderson S; Tang T; Sun P; Johnson N; Fletcher O; Dos Santos Silva I; Peto J; Boshoff C; Narod S; Petronis A
Hum Mol Genet; 2009 Apr; 18(7):1332-42. PubMed ID: 19153073
[TBL] [Abstract][Full Text] [Related]
52. No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.
Mikeska T; Carney DA; Seymour JF; Dobrovic A
Leuk Lymphoma; 2012 Jul; 53(7):1420-2. PubMed ID: 22204453
[No Abstract] [Full Text] [Related]
53. The minimal Tumor Suppressor in Lung Cancer-1 promoter is restrained by an inhibitory region.
Hori RT
Mol Biol Rep; 2010 Apr; 37(4):1979-85. PubMed ID: 19653122
[TBL] [Abstract][Full Text] [Related]
54. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
55. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
[TBL] [Abstract][Full Text] [Related]
56. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
[TBL] [Abstract][Full Text] [Related]
57. The ATM gene and susceptibility to childhood T-cell acute lymphoblastic leukaemia.
Takeuchi S; Koike M; Park S; Seriu T; Bartram CR; Taub HE; Williamson IK; Grewal J; Taguchi H; Koeffler HP
Br J Haematol; 1998 Nov; 103(2):536-8. PubMed ID: 9827931
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
[TBL] [Abstract][Full Text] [Related]
59. Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.
Kloth JN; Gorter A; ter Haar N; Corver WE; Jordanova ES; Kenter GG; Fleuren GJ
Mol Immunol; 2008 Jan; 45(1):152-9. PubMed ID: 17560652
[TBL] [Abstract][Full Text] [Related]
60. Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.
Oliveira AM; Ross JS; Fletcher JA
Am J Clin Pathol; 2005 Dec; 124 Suppl():S16-28. PubMed ID: 16468415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
